First-quarter earnings have continued to come in strong, though Big Tech is very much in the driver’s seat.

Adaptimmune (NASDAQ:ADAP) is scheduled to announce Q1 earnings results on Tuesday, May 13th, after market close. The consensus EPS Estimate is -$0.17 and the consensus Revenue Estimate is $6.55M (+14.

Itaú Unibanco shows resilient growth with record profits, lower NPLs, and strong credit quality despite FX impacts on ...

The game industry’s motto for all of last year was "survive til 2025." And in some respects, that wasn't just wishful ...

South Africa's MTN Group , on Monday, reported a 33% jump in first-quarter core profit due to strong service revenue growth, ...

DraftKings reported first-quarter revenue of $1.41 billion, up 20% year-over-year. The revenue total missed a Street ...

This projection indicates a 21% year-over-year drop in earnings and a 9% decrease in sales compared to last year’s figures of ...

Highway Releases Freight Fraud Index Revealing 400,000 Sophisticated Fraud Attempts in Q1 2025 ...

The interim report for Q1 2025 is enclosed. In connection with publication of the results for Q1 2025, a conference call will be hosted on 13 May 2025 at 10:00 AM CEST. The conference call will be ...

Cheniere Energy , the largest U.S. liquefied natural gas exporter, beat first-quarter estimates for core profit and revenue ...

Huya (NYSE:HUYA) is scheduled to announce Q1 earnings results on Tuesday, May 13th, before market open. The consensus EPS ...